Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 94 peer-reviewed journal articles Updated
Medical Genetics

The Angelman Syndrome Resource Guide

At a Glance

Angelman syndrome is a rare genetic disorder caused by a missing or inactive UBE3A gene. It causes developmental delays, speech impairment, and movement issues. While individuals require lifelong care, they generally have a normal lifespan and a distinctively happy, sociable personality.

Welcome to the Angelman Syndrome Resource Guide. Receiving a diagnosis of Angelman syndrome (AS) for your child can feel like a tidal wave of information and emotion. You may be hearing terms like “severe intellectual disability,” “genetic deletion,” and “neurodevelopmental disorder” for the first time [1]. It is important to know that while AS is a significant, life-long condition, your child’s diagnosis is a roadmap, not a barrier to a joyful and meaningful life.

Angelman syndrome is a rare genetic disorder occurring in approximately 1 in 15,000 to 1 in 30,000 live births [2]. It primarily affects the nervous system, leading to severe developmental delays, speech impairment, issues with movement and balance (ataxia), and characteristic behaviors like a frequently happy, sociable demeanor [3]. The underlying cause is the loss of function of the maternally inherited UBE3A gene on chromosome 15 [4].

In the early days of a diagnosis, focusing on a few stabilizing facts can help anchor your family:

  • It is not your fault: Angelman syndrome is almost always a random genetic event. It was not caused by anything you did or did not do during pregnancy.
  • Life expectancy is generally normal: While people with AS require lifelong care, they generally have a normal lifespan [2].
  • A distinctive personality: One of the most unique features of AS is a genuinely happy, sociable personality with easily triggered laughter [3]. While this is a medical symptom, it often becomes a cherished part of a child’s identity.
  • Hope on the horizon: Groundbreaking research into gene-modifying therapies is currently underway, offering hope that we may eventually treat the root cause of the syndrome [5].

This guide is designed to empower you with evidence-based information, practical management strategies, and questions to help you advocate for your child.

Explore the Guide

01

Introduction to Angelman Syndrome: What It Is and What to Expect First

Learn the basics of Angelman syndrome, a rare neurodevelopmental disorder. Discover causes, key symptoms like ataxia and seizures, and what to expect.

02

Recognizing and Understanding Symptoms of Angelman Syndrome

Learn to recognize the core symptoms of Angelman syndrome, including developmental delays, speech impairment, ataxia, sleep issues, and a happy demeanor.

03

The Genetics of Angelman Syndrome: UBE3A, Subtypes, and Your Diagnosis

Understand the genetics of Angelman syndrome. Learn about the UBE3A gene, the four genetic subtypes, diagnostic testing, and what it means for your child.

04

Navigating Seizures, Sleep, and Medical Care in Angelman Syndrome

Learn how to manage Angelman syndrome medical care, including seizure medications, the LGIT diet, sleep disturbances, GI issues, and long-term bone health.

05

Building Your Child's Care Team: Therapies and Communication Strategies

Learn how to build an effective care team for your child with Angelman syndrome. Discover key therapies, including AAC for communication, PT, and OT.

06

The Horizon: Emerging Treatments and Research in Angelman Syndrome

Discover emerging treatments for Angelman syndrome. Learn how ASO therapies and clinical trials aim to unsilence the UBE3A gene and treat the root cause of AS.

Common questions in this guide

What causes Angelman syndrome?
Angelman syndrome is typically caused by a random genetic event that results in the loss of function of the maternally inherited UBE3A gene on chromosome 15. It is not caused by anything a parent did or did not do during pregnancy.
What is the life expectancy for someone with Angelman syndrome?
While individuals with Angelman syndrome require lifelong care and support for their developmental and medical needs, they generally have a normal lifespan.
What are the main symptoms of Angelman syndrome?
Primary symptoms include severe developmental delays, speech impairment, movement and balance issues known as ataxia, and a characteristically happy, sociable demeanor with easily triggered laughter.
Why is it important to know my child's genetic subtype?
Knowing the exact genetic subtype helps your child's medical team understand their specific prognosis. This information acts as a roadmap for anticipating care needs and managing symptoms effectively throughout their life.
Are there treatments available for Angelman syndrome?
Currently, care focuses on managing symptoms through a multidisciplinary team addressing sleep, seizures, and developmental therapies. However, groundbreaking research into gene-modifying therapies is underway, offering hope for treating the root cause.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific genetic subtype of Angelman syndrome does my child have, and how does this affect their prognosis?
  2. 2.Who should be the primary point of contact or 'quarterback' for my child's multidisciplinary care team?
  3. 3.Are there any current clinical trials or patient registries you recommend we join to stay informed about emerging therapies?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (5)
  1. 1

    Caregiving Burden and Quality of Life Among Parents of Individuals With Angelman Syndrome: Gender Differences and the Impact of Financial Well-Being.

    Walkowiak D, Domaradzki J

    Pediatric neurology 2025; (169()):31-39 doi:10.1016/j.pediatrneurol.2025.05.005.

    PMID: 40449417
  2. 2

    Community-Sourced Reporting of Mortalities in Angelman Syndrome (1979-2022).

    Gomes AT, Moore A, Cross M, et al.

    American journal of medical genetics. Part A 2025; (197(4)):e63961 doi:10.1002/ajmg.a.63961.

    PMID: 39679858
  3. 3

    Atypical presentation of Angelman syndrome with intact expressive language due to low-level mosaicism.

    Punatar R, Egense A, Mao R, et al.

    Molecular genetics & genomic medicine 2022; (10(10)):e2018 doi:10.1002/mgg3.2018.

    PMID: 35929060
  4. 4

    Angelman syndrome - insights into a rare neurogenetic disorder.

    Buiting K, Williams C, Horsthemke B

    Nature reviews. Neurology 2016; (12(10)):584-93 doi:10.1038/nrneurol.2016.133.

    PMID: 27615419
  5. 5

    An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the UBE3A-AS transcript.

    Dindot SV, Christian S, Murphy WJ, et al.

    Science translational medicine 2023; (15(688)):eabf4077 doi:10.1126/scitranslmed.abf4077.

    PMID: 36947593

This guide provides educational information about Angelman syndrome for families. It does not replace professional medical advice. Always consult your child's healthcare team to discuss specific care and treatment plans.

Get notified when new evidence is published on Angelman syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.